Effects of the alpha‐2 adrenoceptor agonist guanfacine on attention and working memory in aged non‐human primates
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
Alpha‐2 adrenergic receptors are potential targets for ameliorating cognitive deficits associated with aging as well as certain pathologies such as attention deficit disorder, schizophrenia and Parkinson’s disease. Although the alpha‐2 agonist guanfacine has been reported to improve working memory in aged primates, it has been difficult to assess the extent to which these improvements may be related to drug effects on attention and/or memory processes involved in task performance. The present study investigated effects of guanfacine on specific attention and memory tasks in aged monkeys. Four Rhesus monkeys (18–21 years old) performed a sustained attention (continuous performance) task and spatial working memory task (self‐ordered spatial search) that has minimal demands on attention. Effects of a low (0.0015 mg/kg) and high (0.5 mg/kg) dose of gunafacine were examined. Low‐dose guanfacine improved performance on the attention task [i.e. decreased omission errors by 50.8 ± 4.3% (P = 0.001) without an effect on commission errors] but failed to improve performance on the spatial working memory task. The high dose of guanfacine had no effects on either task. Guanfacine may have a preferential effect on some aspects of attention in normal aged monkeys and in doing so may also improve performance on other tasks, including some working memory tasks that have relatively high attention demands.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnsten, A., Cai, J., & Goldman-Rakic, P. (1988) · The Journal of Neuroscience · doi:10.1523/jneurosci.08-11-04287.1988 · Cited by 391 · cited 8×
“…of Neuroscience ª 2011 Federation of European Neuroscience Societies and Blackwell Publishing Ltd European Journal of Neuroscience, 34, 1018–1022 example, in one study (Arnsten et al., 1988), guanfacine had a significant and robust effect on performance of aged animals on a variable DR task.”
InfluentialGamo, N. J., Wang, M., & Arnsten, A. F. T. (2010) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1016/j.jaac.2010.06.015 · Cited by 232 · cited 1×
“Improvement of DR performance has also recently been shown after administration of methylphenidate or atomoxetine, with effects attributed to indirect stimulation of alpha-2 adrenoceptors and D1 dopamine receptors in the prefrontal cortex (Gamo et al., 2010).”
Taylor, F. B., & Russo, J. (2001) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-200104000-00015 · Cited by 189 · cited 2×
“disorder (ADHD), guanfacine improved the measure of sustained attention but not a measure of divided attention (Taylor and Russo 2001).”
Chamberlain, S. R., Robbins, T. W., Winder-Rhodes, S., Müller, U., Sahakian, B. J., Blackwell, A. D., & Barnett, J. H. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2010.08.019 · Cited by 178
Arnsten, A. F. T., & Contant, T. A. (1992) · Psychopharmacology · doi:10.1007/bf02245302 · Cited by 168 · cited 4×
“After administration of clonidine or guanfacine, performance was not impaired on distracter or non-distracter trials, suggesting that these drugs have a positive effect on attention but may also be able to protect memory from irrelevant stimulation (Arnsten & Contant, 1992).”
InfluentialArnsten, A. F. T., & Goldman-Rakic, P. S. (1990) · Neurobiology of Aging · doi:10.1016/0197-4580(90)90021-q · Cited by 88 · cited 2×
“These results differ somewhat from results of other studies that examined the effects of guanfacine on cognition in aged non-human primates (Arnsten et al., 1988; Arnsten & Goldman-Rakic, 1990; Rama et al., 1996; Franowicz & Arnsten, 1998; Buccafusco et al., 2009).”
Lack of effects of guanfacine on executive and memory functions in healthy male volunteers
Müller, U., Clark, L., Lam, M. L., Moore, R. M., Murphy, C. L., Richmond, N. K., Sandhu, R. S., Wilkins, I. A., Menon, D. K., Sahakian, B. J., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0078-4 · Cited by 73 · cited 2×
“and memory in healthy volunteers (using a human equivalent of the SOSS task used in the current study), guanfacine had no effect on spatial working memory performance (Muller et al., 2005).”
Effects of guanfacine on three forms of distraction in the aging macaque
O'Neill, J., Fitten, L. J., Siembieda, D. W., Ortiz, F., & Halgren, E. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00681-0 · Cited by 32
Cannon, M., Pelham, W. H., Sallee, F. R., Palumbo, D. R., Bukstein, O., & Daviss, W. B. (2009) · Journal of Child and Adolescent Psychopharmacology · doi:10.1089/cap.2009.0008 · Cited by 29
Cited by
Mather, M., Clewett, D., Sakaki, M., & Harley, C. W. (2016) · Behavioral and Brain Sciences · doi:10.1017/s0140525x15000667 · Cited by 695
Logue, S. F., & Gould, T. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.08.007 · Cited by 477
Hassani, S. A., Oemisch, M., Balcarras, M., Westendorff, S., Ardid, S., van der Meer, M. A., Tiesinga, P., & Womelsdorf, T. (2017) · Scientific Reports · doi:10.1038/srep40606 · Cited by 360
Linking ADHD to the Neural Circuitry of Attention
Mueller, A., Hong, D. S., Shepard, S., & Moore, T. (2017) · Trends in Cognitive Sciences · doi:10.1016/j.tics.2017.03.009 · Cited by 158
A behavioral neuroenergetics theory of ADHD
Killeen, P. R., Russell, V. A., & Sergeant, J. A. (2013) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2013.02.011 · Cited by 97
Metadata
- Authors
- Decamp, E., Clark, K., & Schneider, J. S.
- Venue
- European Journal of Neuroscience
- Publisher
- Wiley
- Published
- 2011-08-23
- Volume
- 34
- Issue
- 6
- Pages
- 1018-1022
- ISSN
- 0953-816X (ISSN-L)
- 1460-9568
- OpenAlex
- W1487828342
- Cited by
- 23
- References
- 9
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Effects of the alpha‐2 adrenoceptor agonist guanfacine on attention and working memory in aged non‐human primates. https://app.cochat.ai/papers/10.1111/j.1460-9568.2011.07815.x
- The paper
- Decamp, E., Clark, K., & Schneider, J. S. (2011). Effects of the alpha‐2 adrenoceptor agonist guanfacine on attention and working memory in aged non‐human primates. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.2011.07815.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.